BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11778810)

  • 1. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.
    Ellis MF; Daniell M
    Clin Exp Ophthalmol; 2001 Dec; 29(6):394-9. PubMed ID: 11778810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
    Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
    Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abobotulinum toxin A (Dysport) and botulinum toxin type A (Botox) for purposeful induction of eyelid ptosis.
    Reddy UP; Woodward JA
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):489-91. PubMed ID: 20724861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective ptosis by botulinum A toxin injection in corneal affectations].
    Gusek-Schneider GC; Erbguth F
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):15-22. PubMed ID: 9743934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis.
    Fuchsluger T; Tuerkeli E; Westekemper H; Esser J; Steuhl KP; Meller D
    Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):955-64. PubMed ID: 17219124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin injection for production of ptosis].
    Merté RL; Lanzl IM
    Ophthalmologe; 2007 Sep; 104(9):767-70. PubMed ID: 17846779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
    Yücel OE; Artürk N
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin A-induced protective ptosis in corneal disease.
    Kirkness CM; Adams GG; Dilly PN; Lee JP
    Ophthalmology; 1988 Apr; 95(4):473-80. PubMed ID: 3050691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing ptosis after botulinum treatment.
    Scott AB
    Ophthalmic Plast Reconstr Surg; 1997 Jun; 13(2):81-3. PubMed ID: 9185190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior rectus underaction following botulinum toxin injection to induce protective upper eye lid ptosis--a comparative study of two techniques.
    Sadiq SA; Dharmasena A
    Strabismus; 2014 Sep; 22(3):111-4. PubMed ID: 25005249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and efficacy of botulinum toxin in hemifacial spasm].
    Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A
    J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficacy and safety of botulinum toxin type A injection in patients requiring temporary tarsorrhaphy to improve corneal epithelial defects.
    Kasaee A; Musavi MR; Tabatabaie SZ; Hashemian MN; Mohebbi S; Khodabandeh A; Rajabi MT
    Int J Ophthalmol; 2010; 3(3):237-40. PubMed ID: 22553562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Persistent corneal defects treated with botulinum toxin-induced ptosis].
    Vleming EN; Pérez-Rico C; Montes MA; Pareja J
    Arch Soc Esp Oftalmol; 2007 Sep; 82(9):547-50. PubMed ID: 17846944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporary tarsorrhaphy induced with type A botulinum toxin.
    Wuebbolt GE; Drummond G
    Can J Ophthalmol; 1991 Dec; 26(7):383-5. PubMed ID: 1764645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of botulinum A toxin in patients at risk of wound complications following eyelid reconstruction.
    Choi JC; Lucarelli MJ; Shore JW
    Ophthalmic Plast Reconstr Surg; 1997 Dec; 13(4):259-64. PubMed ID: 9430303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study.
    Flynn TC; Carruthers JA; Carruthers JA; Clark RE
    Dermatol Surg; 2003 Sep; 29(9):943-50; discussion 950-1. PubMed ID: 12930337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
    Steinsapir KD; Groth MJ; Boxrud CA
    Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single transcutaneous injection with Botox for dysthyroid lid retraction.
    Shih MJ; Liao SL; Lu HY
    Eye (Lond); 2004 May; 18(5):466-9. PubMed ID: 15131675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study.
    Träisk F; Tallstedt L
    Acta Ophthalmol Scand; 2001 Dec; 79(6):585-8. PubMed ID: 11782224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of brow lifting using botulinum a toxin on upper eyelid height in patients with ptosis undergoing the frontal sling technique.
    Isik D; Tekin H; Karadag R; Bilgili SG; Atik B
    Ann Plast Surg; 2013 Feb; 70(2):175-9. PubMed ID: 22791060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.